• CAR-T: A Promising Breakthrough in Fungal Infection Treatment—Insights from ECCMID 2023

    The 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) held in Copenhagen, Denmark, from April 15th to 18th, 2023, brought together experts in the field to discuss the…

  • Interview with Chao Zhuo at ECCMID 2023

    The 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) took place in Copenhagen, Denmark, from April 15th to 18th, 2023. As one of the most significant conferences in the field of clinical microbiology and infectious diseases, it marked a significant gathering after a three-year hiatus due to the pandemic. Chinese experts, including Dr.…

  • Dr. Heather-Marie Schmidt: WHO Long-Acting PrEP Guidelines and Priority Actions to End HIV Epidemic in Asia  

    Heather-Marie Schmidt BMedSc (Hon), MPH, PhD Dr. Schmidt serves as the Regional Advisor on HIV Testing, Prevention, and Key Populations for the Joint United Nations Programme on HIV/AIDS (UNAIDS) Asia-Pacific Regional Office and the World Health Organization (WHO) Global HIV, Hepatitis, and Sexually Transmitted Infections Program. She is dedicated to developing global guidelines for PrEP…

  • Dr. Hongzhou Lu: Focus on the Aging of HIV/AIDS Patients, Intrinsic Capacity Assessment is Imperative!

    In recent years, with the effectiveness of antiretroviral therapy (ART) in suppressing HIV replication, the life expectancy of HIV-infected individuals has significantly increased. At the same time, the trend of aging among HIV/AIDS patients has gradually become a research hotspot in the field. From June 8th to 10th, 2023, the Asia Pacific AIDS and Co-infections…

  • Dr. Iskandar Azwa: Second and Third-Line Treatment Options for HIV/AIDS Patients

    Dr. Iskandar Azwa Chairman of the Malaysian AIDS Council, Head of Infectious Diseases Department at the University of Malaya Medical Center. His research interests include pre-exposure prophylaxis (PrEP) implementation in key populations, HIV drug resistance, and evaluating new HIV treatment strategies. He is the principal investigator for several international collaborative HIV clinical trials, including TAHOD,…

  • Dr. Jennifer Hoy: How to Safely Transition ART in HIV Patients Achieving Viral Suppression?

    Infectious Disease/HIV Specialist and Medical Professor at Monash University Alfred Hospital, Australia. Member of the Australian Antiretroviral Guidelines Committee and the International Antiviral Society-USA (IAS-USA) Antiretroviral Guidelines Panel. Leading and participating in the development of new antiretroviral drugs and the prevention and management of opportunistic infections, with a primary research focus on complications related to…

  • Dr. Dong Xu: Meeting More Patient Needs in HIV Health Management

    Implementation Science is a relatively new and increasingly recognized field of research. Its purpose is to translate the possibilities outlined in theory into practical applications in the real world, addressing the challenges of implementing validated intervention measures. At the 2023 APACC conference, Dr. Dong Hsu, from the School of Public Health Management and the Global…

  • Dr. Lang Bai: The Impact and Mechanism of TmPV1 Fungivirus on Talaromyces Marneffei Virulence

    Over the years, significant progress has been made in the prevention and treatment of HIV/AIDS and co-infections. Society has provided the best medications and professional knowledge to combat HIV infections, making substantial contributions to those affected. From June 8th to 10th, 2023, the Asia-Pacific AIDS and Co-Infections Conference (APACC 2023) was held in Singapore. In…